A novel assay for antibody-dependent cell-mediated cytotoxicity against HIV-1- or SIV-infected cells reveals incomplete overlap with antibodies measured by neutralization and binding assays
about
Antibody responses to envelope glycoproteins in HIV-1 infectionAAV-Delivered Antibody Mediates Significant Protective Effects against SIVmac239 Challenge in the Absence of Neutralizing ActivityIn vivo administration of a JAK3 inhibitor during acute SIV infection leads to significant increases in viral load during chronic infectionTetherin Antagonism by HIV-1 Group M Nef Proteins.Immunopathogenesis of simian immunodeficiency virus infection in nonhuman primatesTetherin antagonism by Vpu protects HIV-infected cells from antibody-dependent cell-mediated cytotoxicity.Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination.AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges.Prospects for engineering HIV-specific antibodies for enhanced effector function and half-life.Envelope Glycoprotein Internalization Protects Human and Simian Immunodeficiency Virus-Infected Cells from Antibody-Dependent Cell-Mediated Cytotoxicity.Strong, but Age-Dependent, Protection Elicited by a Deoxyribonucleic Acid/Modified Vaccinia Ankara Simian Immunodeficiency Virus VaccineA new cell line for high throughput HIV-specific antibody-dependent cellular cytotoxicity (ADCC) and cell-to-cell virus transmission studies.Comparison of Antibody-Dependent Cell-Mediated Cytotoxicity and Virus Neutralization by HIV-1 Env-Specific Monoclonal Antibodies.Epitope specificity of human immunodeficiency virus-1 antibody dependent cellular cytotoxicity [ADCC] responses.Comparison of antibodies that mediate HIV type 1 gp120 antibody-dependent cell-mediated cytotoxicity in asymptomatic HIV type 1-positive men and women.A modified vaccinia Ankara vaccine vector expressing a mosaic H5 hemagglutinin reduces viral shedding in rhesus macaques.Antibody Functional Assays as Measures of Fc Receptor-Mediated Immunity to HIV - New Technologies and their Impact on the HIV Vaccine Field.Pharmacologic Inhibition of Nedd8 Activation Enzyme Exposes CD4-Induced Epitopes within Env on Cells Expressing HIV-1.Vaccine-induced immune responses against both Gag and Env improve control of simian immunodeficiency virus replication in rectally challenged rhesus macaques.Systems serology: profiling vaccine induced humoral immunity against HIV.eCD4-Ig promotes ADCC activity of sera from HIV-1-infected patients.Reduced cell-associated DNA and improved viral control in macaques following passive transfer of a single anti-V2 monoclonal antibody and repeated SHIV challenges.eCD4-Ig variants that more potently neutralize HIV-1.Correlates of Protection Against SIVmac251 Infection in Rhesus Macaques Immunized With Chimpanzee-Derived Adenovirus Vectors.Application of area scaling analysis to identify natural killer cell and monocyte involvement in the GranToxiLux antibody dependent cell-mediated cytotoxicity assay.Uninfected Bystander Cells Impact the Measurement of HIV-Specific Antibody-Dependent Cellular Cytotoxicity Responses.
P2860
Q26991572-4D7A7967-3385-4CAA-8297-DE8CC82BEC7EQ27318266-FF55C2D9-F52A-484E-9943-AFAE689BE9B9Q27330386-FAF50F78-791B-42A9-8348-73CB3650C690Q30393226-387D75DE-DAFD-4D2E-87F6-D659E44E8034Q33355730-7AD07920-A233-4BAE-8416-5DD3349811C7Q33674461-7C13175B-7412-451A-A983-1E11F8554393Q33977866-3E390FC6-AA8E-4571-9E07-B0E116E1AB28Q34464133-5A5F7C4B-A901-4513-978D-64DAB946FCEEQ35569901-5F9F911C-08F9-47E0-B323-26AE5C58C114Q36086204-2B2D8E90-D09B-49EE-BA7D-8A4258D3A274Q36708266-3826BD1D-5EE0-40AE-8742-F5235316D972Q36906910-D0E6A610-E320-4FE3-84DD-62A349B56DFBQ37002517-3933D1D9-F7F5-4750-B46E-9DB6380DCD04Q37426168-08D76248-03B0-4D0D-A766-82974EC6FAA4Q37460091-EAAB255A-35D7-410F-9EE7-6AA48F3442BBQ38644429-FAC49CB3-707F-4AA3-B75D-50121DD455A4Q39189458-038B2C99-740A-4164-B0C6-1F9588C86F0FQ39604750-62D18DC8-2168-45C0-8009-A7C1B95B9D3DQ40113278-1DDF96C4-CA4F-471A-8D71-276EA2AF5B79Q47104983-4D09AC11-24D3-4F0A-BBC4-D05E6F8BE33CQ47564080-60F573F5-0FF5-47EE-9BDC-E45256759DA8Q51743315-7F8DF5C7-58C7-456E-BB0C-1ECAC9A4CF1AQ52624996-BF6EFF0E-88BA-4DE0-8A2D-075CEDA17940Q53692345-BAEFCF4D-DB68-48AA-AEEC-03E7470A512DQ54263363-CEB9C076-2B34-4AB3-952B-F0A1811D5447Q55411165-3AF6888F-8C7F-455C-BCB2-1E804AB5B35E
P2860
A novel assay for antibody-dependent cell-mediated cytotoxicity against HIV-1- or SIV-infected cells reveals incomplete overlap with antibodies measured by neutralization and binding assays
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
A novel assay for antibody-dep ...... tralization and binding assays
@ast
A novel assay for antibody-dep ...... tralization and binding assays
@en
type
label
A novel assay for antibody-dep ...... tralization and binding assays
@ast
A novel assay for antibody-dep ...... tralization and binding assays
@en
prefLabel
A novel assay for antibody-dep ...... tralization and binding assays
@ast
A novel assay for antibody-dep ...... tralization and binding assays
@en
P2093
P2860
P356
P1433
P1476
A novel assay for antibody-dep ...... tralization and binding assays
@en
P2093
David E J Williams
David T Evans
Lisa N Heyer
Maria Allhorn
Michael D Alpert
Thomas Greenough
P2860
P304
12039-12052
P356
10.1128/JVI.01650-12
P407
P577
2012-08-29T00:00:00Z